HELPLINE
On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD, about the eVOLVE meso clinical trial for patients with pleural mesothelioma. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made…
Caregivers of mesothelioma patients perform crucial duties and bear considerable burdens after a loved one’s diagnosis of mesothelioma. While resources for patients are often available at treatment centers and through organizations like the Mesothelioma Applied Research Foundation, caregivers report a lack of support. Understanding and identifying the needs of caregivers…
The Mesothelioma Applied Research Foundation is excited to announce its latest research grant recipients, awarding a total of $300,000. This brings the Foundation’s…
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free…
The Meso Foundation’s International Symposium on Malignant Mesothelioma is a unique conference that brings together the entire mesothelioma community. We invite patients, their families, caregivers,…
Data from a positive phase 2/3 clinical trial evaluating the effectiveness of a drug for mesothelioma was just published in the Journal of the American…
This week, mesothelioma clinicians and researchers have come together in Lille, France, for the International Mesothelioma Interest Group‘s biannual meeting known as iMig to discuss…
The American Society for Clinical Oncology’s (ASCO) annual meeting concluded last week in Chicago, IL. As the largest oncology meeting in the world, ASCO is…
The Peer Reviewed Cancer Research Program (PRCRP) is soliciting input regarding the Quality of Life (QoL) and psychosocial aspects of cancer care (diagnosis/treatment/transition to survivorship…
This week, the paper “Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations,” by Drs. Michele Carbone, Harvey Pass, and…
